Nephrology

97-104 of 104

• 

  RestartResume

  KDIGO Conversations in Nephrology: Maximizing Filter Life During CRRT – Best Practices on Anticoagulation and Citrate Use

  RestartResume

  KDIGO Conversations in Nephrology: Maximizing Filter Life During CRRT – Best Practices on Anticoagulation and Citrate Use

  Nephrology

  KDIGO Conversations in Nephrology: Maximizing Filter Life During CRRT – Best Practices on Anticoagulation and Citrate Use

  Ravindra L. Mehta, MD; Ashita Tolwani, MD

  • 

    

    Ravindra L. Mehta, MD

  • 

    

    Ashita Tolwani, MD

• 

  RestartResume

  KDIGO Conversations in Nephrology: How to Develop an Acute Dialysis Care Quality Program - Quality Metrics and Continuous Improvement

  RestartResume

  KDIGO Conversations in Nephrology: How to Develop an Acute Dialysis Care Quality Program - Quality Metrics and Continuous Improvement

  Nephrology

  KDIGO Conversations in Nephrology: How to Develop an Acute Dialysis Care Quality Program - Quality Metrics and Continuous Improvement

  Ravindra L. Mehta, MD; Theresa Mottes, APRN-NP, CPNP-AC, CDN

  • 

    

    Ravindra L. Mehta, MD

  • 

    

    Theresa Mottes, APRN-NP, CPNP-AC, CDN

• 

  RestartResume

  KDIGO Conversations in Nephrology: Deciding When and Who Should Start Acute Dialysis - From Evidence to Bedside Practice

  RestartResume

  KDIGO Conversations in Nephrology: Deciding When and Who Should Start Acute Dialysis - From Evidence to Bedside Practice

  Nephrology

  KDIGO Conversations in Nephrology: Deciding When and Who Should Start Acute Dialysis - From Evidence to Bedside Practice

  Ravindra L. Mehta, MD; Marlies Ostermann, MD

  • 

    

    Ravindra L. Mehta, MD

  • 

    

    Marlies Ostermann, MD

• 

  RestartResume

  AFFIRM-AHF: Key Takeaways

  RestartResume

  AFFIRM-AHF: Key Takeaways

  Global Heart Failure Academy

  AFFIRM-AHF: Key Takeaways

  Ewa A. Jankowska, MD, PhD, FESC

  • 

    

    Ewa A. Jankowska, MD, PhD, FESC

• 

  RestartResume

  Late-breaking First Response on AFFIRM-AHF

  RestartResume

  Late-breaking First Response on AFFIRM-AHF

  Global Heart Failure Academy

  Late-breaking First Response on AFFIRM-AHF

  Stefan D. Anker, MD, PhD; Javed Butler, MD

  • 

    

    Stefan D. Anker, MD, PhD

  • 

    

    Javed Butler, MD

  • 

    

    Ewa A. Jankowska, MD, PhD, FESC

  • 

    

    Josep Comin-Colet, MD, PhD

• 

  RestartResume

  CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy

  RestartResume

  CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy

  Global Heart Failure Academy

  CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy

  Mikhail Kosiborod, MD

  • 

    

    Mikhail Kosiborod, MD

• 

  RestartResume

  Balancing RAASi Therapy and Potassium: Understanding How it Works

  RestartResume

  Balancing RAASi Therapy and Potassium: Understanding How it Works

  Global Heart Failure Academy

  Balancing RAASi Therapy and Potassium: Understanding How it Works

• 

  RestartResume

  Mechanisms in Heart Failure: Why Iron Deficiency Matters

  RestartResume

  Mechanisms in Heart Failure: Why Iron Deficiency Matters

  Global Heart Failure Academy

  Mechanisms in Heart Failure: Why Iron Deficiency Matters

• Previous
• 1
• 2
• …
• 5
• 6
• 7
• Next